Gimeracil

Gimeracil
  • CAS No.:103766-25-2
Other grades of this product :
Gimeracil Basic information
Product Name:Gimeracil
Synonyms:GIMERACIL;gimestat;5-Chloro-2,4-dihydroxypyridine;5-Chloro-4-hydroxy-2(1H)-pyridinone;5-Chloro-4-hydroxy-2-pyridone;2(1H)-Pyridinone,5-chloro-4-hydroxy-(9CI);5-chloropyridine-2,4-diol;2(1H)-Pyridinone, 5-chloro-4-hydroxy-
CAS:103766-25-2
MF:C5H4ClNO2
MW:145.54
EINECS:1312995-182-4
Product Categories:Antitumors for Research and Experimental Use;PYRIDINE;Biochemistry;Chloropyridines;oncology;Anticancer;Halopyridines;Intermediates & Fine Chemicals;Pharmaceuticals;103766-25-2
Mol File:103766-25-2.mol
Gimeracil Chemical Properties
Melting point 274 °C
Boiling point 255.1±40.0 °C(Predicted)
density 1.56±0.1 g/cm3(Predicted)
storage temp. Inert atmosphere,Store in freezer, under -20°C
solubility Soluble in DMSO (up to 5 mg/ml).
pka4.50±1.00(Predicted)
form solid
color White
Stability:Stable for 1 year from date of purchase as supplied. Solutions in DMSO may be stored at -20°C for up to 3 months.
InChIKeyZPLQIPFOCGIIHV-UHFFFAOYSA-N
CAS DataBase Reference103766-25-2(CAS DataBase Reference)
Safety Information
Safety Statements 24/25
HS Code 29337900
MSDS Information
Gimeracil Usage And Synthesis
DescriptionGimeracil (103766-25-2) is a dihydropyrimidine dehydrogenase (DPD) inhibitor.? DPD is involved in the degradation of pyrimidine-based chemotherapeutic drugs such as 5-fluorouracil (5-FU).? Gimeracil is used along with 5-FU or Tegafur to prolong circulating concentrations of the drugs.1,2? Gimeracil has also been shown to act as a radiosensitizer via inhibition of homologous recombination in the repair of DNA double strand breaks.3
Chemical PropertiesOff-White Solid
UsesGimeracil is an inhibitor of dihydropyrimidine dehydrogenase, which inhibits the early step in homologous recombination for double strand breaks repair.
UsesGimeracil is an antitumor agent. Gimeracil is a potent inhibitor of dihydropyrimidine dehydrogenase (DPD).
UsesAntitumor agent. A potent inhibitor of dihydropyrimidine dehydrogenase (DPD)
References1) Diasio (1999)?Clinical implications of dihydropyrimidine dehydrogenase inhibition; Oncology(Williston Park),?13?17 2) Kobayakawa and Kojima (2011),?Tegafur/gimeracil/oteracil (S-1) approved for the treatment of advanced gastric cancer in adults when given in combination with cisplatin: a review comparing it with other fluoropyrimidine-based therapies; Onco. Targets Ther.,?4?193 3) Sakata?et al.?(2011),?Gimeracil, an inhibitor of dihydropyrimidine dehydrogenase, inhibits the early step in homologous recombination; Cancer Sci.,?102?1712
Gimeracil Preparation Products And Raw materials

Welcome!

Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.

  • NO. 18 ,Wujiang Road, Wulidian Street, Jiangbei District, Chongqing
  • +86-23-6139-8061 +86-13650506873
  • danny@chemdad.com sales@chemdad.com
  • www.chemdad.com
  • WhatsApp +86-13650506873

Name

phone

company

email

message

Payment methods
Google translate: 日本语日本语 한국어한국어 FrançaisFrançais DeutschDeutsch EspañaEspaña TürkiyeTürkiye